Björn Niebel is a Senior Principal Scientist, Lab Head in the Discovery Department of the Nanobody Research Platform at Sanofi Ghent. Björn received his master’s degree in Chemistry from the University of Braunschweig, Germany in 2006 and holds a PhD in Biochemistry from the University of Bonn, Germany. After 3 years of developing DNA-based medical devices at Relitech, The Netherlands, Björn joined former Ablynx in 2014